Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CVS HEALTH CorpCVS · Entity 2884 | EVP and Chief Medical Officer | April 01, 2022 | April 05, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CVS HEALTH Corp
Report date April 01, 2022 · Filed April 05, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 232,676.059 |
Ending reported balance
After 2022-04-03 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2022-04-01 · Tax withholding · Disposed 77,960 · Balance 234,855.059 F1: Surrender of shares in payment of taxes due upon the vesting and settlement of the PSUs on April 1, 2022. Row 2 · 2022-04-03 · Tax withholding · Disposed 2,179 · Balance 232,676.059 F2: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock unit award under the Registrant's 2017 Incentive Compensation Plan. |
| Common Stock (restricted)SEC Table I · non-derivative | Direct | 4,805 |
Reported balance
Holding disclosure · report date 2022-04-01 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 4,805 |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $104.82 · Expires 2023-04-01 | Direct | 53,772 |
Reported balance
Holding disclosure · report date 2022-04-01 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 53,772 F3: Option became exercisable in four equal annual installments, commencing 4/1/2017. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $78.05 · Expires 2024-04-03 | Direct | 75,134 |
Reported balance
Holding disclosure · report date 2022-04-01 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 75,134 F4: Option became exercisable in four equal annual installments, commencing 4/3/2018. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $62.21 · Expires 2025-04-01 | Direct | 21,894 |
Reported balance
Holding disclosure · report date 2022-04-01 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 21,894 F5: Option became exercisable in four equal annual installments, commencing 4/1/2019. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $54.19 · Expires 2029-04-01 | Direct | 80,803 |
Reported balance
Holding disclosure · report date 2022-04-01 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 80,803 F6: Option became exercisable in four equal annual installments, commencing 4/1/2020. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $58.34 · Expires 2030-04-01 | Direct | 84,478 |
Reported balance
Holding disclosure · report date 2022-04-01 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 84,478 F7: The number of shares subject to the option were calculated using a 30-day average price. F8: Options became exercisable in four equal annual installments, commencing 4/1/2021. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $74.30 · Expires 2031-04-01 | Direct | 99,344 |
Reported balance
Holding disclosure · report date 2022-04-01 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 99,344 F9: Option becomes exercisable in four equal annual installments, commencing 4/1/2022. |
Filing footnotes · ownership attribution and instrument terms
F1: Surrender of shares in payment of taxes due upon the vesting and settlement of the PSUs on April 1, 2022.
F2: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock unit award under the Registrant's 2017 Incentive Compensation Plan.
F3: Option became exercisable in four equal annual installments, commencing 4/1/2017.
F4: Option became exercisable in four equal annual installments, commencing 4/3/2018.
F5: Option became exercisable in four equal annual installments, commencing 4/1/2019.
F6: Option became exercisable in four equal annual installments, commencing 4/1/2020.
F7: The number of shares subject to the option were calculated using a 30-day average price.
F8: Options became exercisable in four equal annual installments, commencing 4/1/2021.
F9: Option becomes exercisable in four equal annual installments, commencing 4/1/2022.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 01, 2013 Filed Apr 3, 2013 20:31 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 2,233 | $54.53 | $121,765.49 |
DisclosureSEC source: 0001127602-13-013269 · form4.xml · nonDerivative · entry 2 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,061.1502 Read SEC document |
| April 01, 2013 Filed Apr 3, 2013 20:31 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 11,004 | $54.53 | $600,048.12 |
DisclosureSEC source: 0001127602-13-013269 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,919 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2016 and 50% on 4/1/2018. Read SEC document |
| March 19, 2013 Filed Mar 20, 2013 20:20 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 6,222 | $0.00 Strike: $36.23 | $0.00 |
DisclosureSEC source: 0001127602-13-011524 · form4.xml · derivative · entry 8 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,845 Underlying: Common Stock · 6,222 shares Expires 2017-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 4/1/2011. Read SEC document |
| March 19, 2013 Filed Mar 20, 2013 20:20 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 6,222 | $54.00 | $335,988.00 |
DisclosureSEC source: 0001127602-13-011524 · form4.xml · nonDerivative · entry 4 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,636.1502 F1 · shares: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| March 19, 2013 Filed Mar 20, 2013 20:20 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 6,222 | $36.23 | $225,423.06 |
DisclosureSEC source: 0001127602-13-011524 · form4.xml · nonDerivative · entry 3 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,858.1502 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 18, 2013 Filed Mar 20, 2013 20:20 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 28,200 | $0.00 Strike: $36.23 | $0.00 |
DisclosureSEC source: 0001127602-13-011524 · form4.xml · derivative · entry 7 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,067 Underlying: Common Stock · 28,200 shares Expires 2017-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 4/1/2011. Read SEC document |
| March 18, 2013 Filed Mar 20, 2013 20:20 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 28,200 | $54.00 | $1,522,800.00 |
DisclosureSEC source: 0001127602-13-011524 · form4.xml · nonDerivative · entry 2 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,636.1502 F1 · shares: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| March 18, 2013 Filed Mar 20, 2013 20:20 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 28,200 | $36.23 | $1,021,686.00 |
DisclosureSEC source: 0001127602-13-011524 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,836.1502 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 19, 2013 Filed Feb 21, 2013 21:48 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 7,549 | $52.66 | $397,530.34 |
DisclosureSEC source: 0001127602-13-007325 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,636.1502 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 19:58 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 66,548 | $45.07 Strike: $45.07 | $2,999,318.36 |
DisclosureSEC source: 0001127602-12-013290 · form4.xml · derivative · entry 7 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,548 Underlying: Common Stock · 66,548 shares Expires 2019-04-02 F6 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/2/2013. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 19:58 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 48,178 | $0.00 Strike: $28.10 | $0.00 |
DisclosureSEC source: 0001127602-12-013290 · form4.xml · derivative · entry 6 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 48,178 shares Expires 2016-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 4/1/2010. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 19:58 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 2,549 | $45.07 | $114,883.43 |
DisclosureSEC source: 0001127602-12-013290 · form4.xml · nonDerivative · entry 4 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,920.1987 F4 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 19:58 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 16,641 | $45.07 | $750,009.87 |
DisclosureSEC source: 0001127602-12-013290 · form4.xml · nonDerivative · entry 3 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,573 F3 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/2/2015 and 50% on 4/2/2017. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 19:58 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 48,178 | $44.96 | $2,166,116.60 |
DisclosureSEC source: 0001127602-12-013290 · form4.xml · nonDerivative · entry 2 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,469.1987 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F2 · shares: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $44.21 and $45.19 per share. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 19:58 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 48,178 | $28.10 | $1,353,801.80 |
DisclosureSEC source: 0001127602-12-013290 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,647.1987 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2012 Filed Feb 22, 2012 20:49 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 96,354 | $0.00 Strike: $28.10 | $0.00 |
DisclosureSEC source: 0001127602-12-007370 · form4.xml · derivative · entry 5 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,178 Underlying: Common Stock · 96,354 shares Expires 2016-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 4/1/2010. Read SEC document |
| February 21, 2012 Filed Feb 22, 2012 20:49 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 96,354 | $44.03 | $4,242,466.62 |
DisclosureSEC source: 0001127602-12-007370 · form4.xml · nonDerivative · entry 2 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,464.1987 F1 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $44.01 and $44.08 per share. Read SEC document |
| February 21, 2012 Filed Feb 22, 2012 20:49 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 96,354 | $28.10 | $2,707,547.40 |
DisclosureSEC source: 0001127602-12-007370 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,818.1987 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 07, 2012 Filed Feb 9, 2012 22:14 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 5,437 | $43.08 | $234,225.96 |
DisclosureSEC source: 0001127602-12-004959 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,464.1987 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan. Read SEC document |
| April 01, 2011 Filed Apr 5, 2011 20:35 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 66,987 | $34.96 Strike: $34.96 | $2,341,865.52 |
DisclosureSEC source: 0001127602-11-012424 · form4.xml · derivative · entry 4 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,987 Underlying: Common Stock · 66,987 shares Expires 2018-04-01 F2 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2012. Read SEC document |
| April 01, 2011 Filed Apr 5, 2011 20:35 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 17,878 | $34.96 | $625,014.88 |
DisclosureSEC source: 0001127602-11-012424 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,937 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse in two equal installments, 50% on 4/1/2014 and 50% on 4/1/2016. Read SEC document |
| April 01, 2010 Filed Apr 5, 2010 22:14 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 103,267 | $0.00 Strike: $36.23 | $0.00 |
DisclosureSEC source: 0001127602-10-010568 · form4.xml · derivative · entry 4 Brennan Troyen A · CIK 0001351402 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,267 Underlying: Common Stock · 103,267 shares Expires 2017-04-01 F2 · shares: Option becomes exercisable in three equal annual installments, commencing 4/1/2011. Read SEC document |
| April 01, 2010 Filed Apr 5, 2010 22:14 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 9,316 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-10-010568 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,059 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 1997 Incentive Compensation Plan. Restrictions lapse on two equal installments 50% on 4/1/2013 and 50% on 4/1/2015. Read SEC document |
| April 01, 2009 Filed Apr 3, 2009 20:27 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 144,532 | $0.00 Strike: $28.10 | $0.00 |
DisclosureSEC source: 0001127602-09-008780 · form4.xml · derivative · entry 4 Brennan Troyen A · CIK 0001351402 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,532 Underlying: Common Stock · 144,532 shares Expires 2016-04-01 F1 · derivative.exercise_date: Option becomes exercisable in three equal installments, commencing 4/1/2010. Read SEC document |
| April 01, 2009 Filed Apr 3, 2009 20:27 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 12,011 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-09-008780 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,743 F2 · shares: Consists of Restricted Stock Units awarded pursuant to issuer's 1997 Incentive Compensation Plan. Restrictions lapse on two equal installments 50% on 4/1/2012 and 50% on 04/01/2014. Read SEC document |
| November 17, 2008 Filed Nov 18, 2008 20:53 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 106,160 | $0.00 Strike: $28.26 | $0.00 |
DisclosureSEC source: 0001127602-08-009578 · form4.xml · derivative · entry 4 Brennan Troyen A · CIK 0001351402 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,160 Underlying: Common Stock · 106,160 shares Expires 2018-11-17 F2 · derivative.exercise_date: Option becomes exercisable in three equal annual installments, commencing 11/17/2011. Read SEC document |
| November 17, 2008 Filed Nov 18, 2008 20:53 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (pep) | 10,616 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-08-009578 · form4.xml · nonDerivative · entry 3 Brennan Troyen A · CIK 0001351402 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,616 Read SEC document |
| November 17, 2008 Filed Nov 18, 2008 20:53 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 9,732 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-08-009578 · form4.xml · nonDerivative · entry 2 Brennan Troyen A · CIK 0001351402 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,732 F1 · shares: Consists of Restricted Stock Units awarded pursuant to issuer's 1997 Incentive Compensation Plan. Restrictions lapse on 11/17/2013. Read SEC document |
| November 17, 2008 Filed Nov 18, 2008 20:53 UTC | CVS HEALTH Corp CVS · Entity 2884 | PurchaseCommon Stock | 10,616 | $28.26 | $300,008.16 |
DisclosureSEC source: 0001127602-08-009578 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,616 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.